Home> Products> multiple pathophysiological defects

{ "products": [ { "_id": "68fcb453ba48b3ee8857fd47", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin Phosphate Monhydrate 64.25 mg, Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg & Glimepirde 1 mg", "description": "ST GLIPTIN GM is a high-quality, fixed-dose combination oral antidiabetic medication containing Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg. This triple-combination therapy is specifically formulated to provide effective glycemic control in adults with type 2 diabetes mellitus (T2DM) who require multiple agents to achieve adequate blood sugar control.\nST GLIPTIN GM works through complementary mechanisms to target the core pathophysiological defects of T2DM—insulin resistance, impaired insulin secretion, and increased hepatic glucose output—making it an ideal choice for patients requiring intensified therapy.\nKey Indications:\nST GLIPTIN GM is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when dual therapy with any two of the individual components (Sitagliptin, Metformin, or Glimepiride) does not provide adequate control.\nMechanism of Action:\nSitagliptin (50 mg):\nA Dipeptidyl Peptidase-4 (DPP-4) inhibitor that enhances the levels of active incretin hormones (GLP-1 and GIP), increasing insulin release and decreasing glucagon secretion in a glucose-dependent manner.\nMetformin Hydrochloride (1000 mg):\nA biguanide that improves insulin sensitivity by decreasing hepatic glucose production and enhancing peripheral glucose uptake.\nGlimepiride (1 mg):\nA sulfonylurea that stimulates pancreatic β-cells to secrete insulin, thereby reducing blood glucose levels.\nThe combination targets multiple metabolic pathways to provide synergistic and sustained blood glucose control.\nDosage and Administration:\nRecommended Dose:\nOne tablet daily, preferably with meals to reduce gastrointestinal side effects.\nIndividualization Required:\nDosage should be tailored based on patient response, renal function, and physician assessment.\nRenal Monitoring:\nBaseline and periodic assessment of renal function is advised, particularly due to the metformin component.\nKey Benefits of ST GLIPTIN GM 50/1000/1:\nTriple Mechanism of Action:\nTargets insulin resistance, insufficient insulin secretion, and excessive hepatic glucose production.\nEnhanced Glycemic Control:\nEffective in achieving and maintaining HbA1c targets.\nOnce-Daily Convenience:\nImproves adherence by reducing pill burden in patients requiring combination therapy.\nWeight Neutral to Modest Reduction:\nMetformin and sitagliptin components support weight neutrality.\nLow Hypoglycemia Risk:\nSitagliptin and metformin carry minimal hypoglycemia risk; however, glimepiride may increase the risk—monitor accordingly.\nSafety and Precautions:\nHypoglycemia:\nMay occur, particularly due to the glimepiride component. Educate patients on recognizing and managing low blood sugar.\nLactic Acidosis:\nA rare but serious complication of metformin. Avoid in patients with significant renal impairment or conditions predisposing to hypoxia.\nRenal Function:\nDose adjustment or discontinuation may be needed based on renal function.\nPancreatitis:\nRare reports with DPP-4 inhibitors like sitagliptin. Discontinue if suspected.\nAllergic Reactions:\nDiscontinue use if hypersensitivity reactions occur.\nPossible Side Effects:\nWhile ST GLIPTIN GM is generally well-tolerated, some patients may experience:\nNausea\nDiarrhea\nHeadache\nHypoglycemia (especially in elderly or with missed meals)\nAbdominal discomfort\nUpper respiratory tract infections\nDizziness\nFlatulence\nIf any side effects persist or worsen, seek immediate medical advice.\nStorage Instructions:\nStore at a temperature below 30°C.\nProtect from moisture and direct sunlight.\nKeep out of reach of children.\nWhy Choose ST GLIPTIN GM 50/1000/1?\nST GLIPTIN GM provides a powerful and synergistic combination of three well-established antidiabetic agents in a single, convenient daily dose. It offers a comprehensive approach to managing type 2 diabetes by addressing multiple metabolic abnormalities with a focus on safety, efficacy, and patient compliance. Manufactured under stringent GMP-certified conditions, ST GLIPTIN GM ensures quality, reliability, and therapeutic confidence for both patients and prescribers.", "price": 285.0, "discountamount": 86.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2188, "imageuri": "https://productimages.withfloats.com/actual/68fcb456f31288eaa96accfa.png", "tileimageuri": "https://productimages.withfloats.com/tile/68fcb456f31288eaa96accfa.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-25T11:28:19.425Z", "updatedon": "2026-03-13T10:40:20.1Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-phosphate-monhydrate-64-25-mg-sitagliptin-50-mg-metformin-hydrochloride-1000-mg-glimepirde-1-mg/2188", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM 50+1000+1", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin 50 mg", "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg", "type 2 diabetes mellitus (T2DM)", "blood sugar control" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "699bfe45e844b0fb29d2bbad", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin 100 Pioglitazone 15 Metformin 500", "description": "Product Name: ST GLIPTIN 3D 500\nComposition: Sitagliptin 100 mg + Pioglitazone 15 mg + Metformin 500 mg\n\nST GLIPTIN 3D 500 is a scientifically formulated triple-combination oral antidiabetic tablet designed to help manage Type 2 Diabetes Mellitus effectively. This advanced formulation combines the proven benefits of Sitagliptin, Pioglitazone, and Metformin to provide comprehensive glycemic control through three complementary mechanisms of action.\n\nThis triple therapy approach is especially beneficial for patients whose blood glucose levels are not adequately controlled with dual therapy or monotherapy. ST GLIPTIN 3D 500 is developed to address multiple metabolic defects associated with Type 2 diabetes, ensuring better long-term glucose management and improved patient outcomes.\n\nProduct Description\n\nST GLIPTIN 3D 500 is an oral antidiabetic medication that works by targeting different physiological pathways involved in glucose regulation:\n\nSitagliptin 100 mg enhances incretin hormone levels, which increase insulin release and decrease glucagon secretion in a glucose-dependent manner.\n\nPioglitazone 15 mg improves insulin sensitivity in muscle and adipose tissues, allowing the body to use insulin more effectively.\n\nMetformin 500 mg reduces hepatic glucose production and improves peripheral glucose uptake.\n\nBy combining these three well-established agents into a single tablet, ST GLIPTIN 3D 500 simplifies diabetes management while improving adherence and therapeutic efficiency.\n\nUses of ST GLIPTIN 3D 500\n\nST GLIPTIN 3D 500 is primarily indicated for:\n\nManagement of Type 2 Diabetes Mellitus\n\nImproving glycemic control in adults\n\nPatients inadequately controlled on metformin alone\n\nIndividuals requiring triple oral therapy\n\nReducing fasting and postprandial blood glucose levels\n\nSupporting long-term HbA1c reduction\n\nIt is typically prescribed alongside lifestyle modifications such as a healthy diet, regular exercise, and weight management.\n\nHow ST GLIPTIN 3D 500 Works\n\nType 2 diabetes is characterized by insulin resistance, decreased insulin secretion, and excessive hepatic glucose production. ST GLIPTIN 3D 500 addresses all three core defects:\n\nEnhances insulin secretion (Sitagliptin) – Works in a glucose-dependent manner, reducing risk of hypoglycemia.\n\nImproves insulin sensitivity (Pioglitazone) – Helps the body respond better to insulin.\n\nReduces glucose production (Metformin) – Decreases sugar release from the liver.\n\nThis comprehensive mechanism makes ST GLIPTIN 3D 500 a powerful therapeutic option for sustained glycemic control.\n\nKey Benefits of ST GLIPTIN 3D 500\n1. Triple Mechanism Advantage\n\nCombines three different classes of antidiabetic agents for broader and more effective blood sugar management.\n\n2. Improved HbA1c Reduction\n\nHelps significantly lower HbA1c levels when compared to monotherapy.\n\n3. Reduced Pill Burden\n\nThree medications in one tablet improve patient compliance and convenience.\n\n4. Better Postprandial Control\n\nHelps manage blood glucose spikes after meals.\n\n5. Insulin Sensitivity Enhancement\n\nPioglitazone improves peripheral glucose utilization.\n\n6. Lower Risk of Hypoglycemia\n\nSitagliptin works in a glucose-dependent manner, minimizing low blood sugar risk when used appropriately.\n\n7. Suitable for Long-Term Management\n\nDesigned for chronic use under medical supervision.\n\nDosage and Administration\n\nThe dosage should be taken strictly as prescribed by a healthcare professional.\n\nUsually administered once daily with meals to reduce gastrointestinal discomfort.\n\nSwallow the tablet whole with water.\n\nDo not crush or chew unless directed by a doctor.\n\nRegular monitoring of blood glucose and HbA1c levels is recommended during therapy.\n\nPossible Side Effects\n\nLike all medications, ST GLIPTIN 3D 500 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects:\n\nNausea\n\nDiarrhea\n\nStomach discomfort\n\nHeadache\n\nUpper respiratory symptoms\n\nLess Common but Important:\n\nWeight gain (associated with Pioglitazone)\n\nFluid retention or edema\n\nLow blood sugar (when combined with other antidiabetic agents)\n\nVitamin B12 deficiency (long-term Metformin use)\n\nRare but Serious:\n\nLactic acidosis (rare, associated with Metformin)\n\nPancreatitis (rare, associated with Sitagliptin)\n\nLiver function abnormalities\n\nPatients should immediately consult a healthcare provider if they experience severe abdominal pain, persistent vomiting, unusual swelling, or breathing difficulties.\n\nPrecautions and Warnings\n\nNot recommended for Type 1 diabetes.\n\nUse cautiously in patients with renal impairment.\n\nLiver function monitoring may be required.\n\nAvoid excessive alcohol consumption.\n\nInform your doctor about any existing heart conditions.\n\nPregnant or breastfeeding women should use this medication only if clearly advised by a healthcare professional.\n\nStorage Instructions\n\nStore below 25°C in a dry place.\n\nKeep away from direct sunlight.\n\nKeep out of reach of children.\n\nWhy Choose ST GLIPTIN 3D 500?\n\nST GLIPTIN 3D 500 stands out as a comprehensive diabetes management solution by combining three powerful and clinically established molecules in one convenient tablet. It is particularly beneficial for patients who require intensified glycemic control without increasing pill burden.\n\nThe triple therapy model helps target multiple metabolic dysfunctions simultaneously, offering better blood glucose stability throughout the day. When used as part of a complete diabetes management plan—including diet, exercise, and routine monitoring—ST GLIPTIN 3D 500 can significantly enhance quality of life and reduce long-term complications associated with uncontrolled diabetes.\n\nConclusion\nST GLIPTIN 3D 500 (Sitagliptin 100 mg + Pioglitazone 15 mg + Metformin 500 mg) represents a modern, evidence-based approach to managing Type 2 Diabetes Mellitus. By addressing insulin resistance, impaired insulin secretion, and excessive glucose production, it provides comprehensive and sustained glycemic control.", "price": 222.0, "discountamount": 67.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2311, "imageuri": "https://productimages.withfloats.com/actual/699bfe47d849febb9bcc2d46.png", "tileimageuri": "https://productimages.withfloats.com/tile/699bfe47d849febb9bcc2d46.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-23T07:14:13.494Z", "updatedon": "2026-03-13T11:04:02.141Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-100-pioglitazone-15-metformin-500/2311", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN 3D 500", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin 100 Pioglitazone 15 Metformin 500 tablet uses", "Sitagliptin Pioglitazone Metformin triple therapy dosage", "Sitagliptin 100 mg Pioglitazone 15 mg Metformin 500 mg benefits", "Triple combination tablet for type 2 diabetes control", "Sitagliptin Pioglitazone Metformin side effects in adults", "How to take Sitagliptin Pioglitazone Metformin tablet", "Sitagliptin Metformin Pioglitazone price in India", "Buy Sitagliptin 100 Pioglitazone 15 Metformin 500 online", "Order Sitagliptin Pioglitazone Metformin tablets", "Sitagliptin 100 Pioglitazone 15 Metformin 500 price", "Sitagliptin triple combination bulk purchase" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69623e6c95697555dd1afd67", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Esomeprazole and Itopride", "description": "ESMOSTRUM IT: Comprehensive Product Guide\nProduct Overview\nESMOSTRUM IT is an advanced pharmaceutical formulation that combines two potent active ingredients—Esomeprazole and Itopride—to provide comprehensive relief from gastrointestinal disorders. This dual-action medication represents a significant advancement in the management of acid-related digestive conditions and motility disorders. By combining a proton pump inhibitor with a prokinetic agent, ESMOSTRUM IT addresses both the underlying causes and symptomatic manifestations of various digestive ailments, offering patients a complete therapeutic solution in a single, convenient dosage form.\nThe synergistic combination of Esomeprazole and Itopride makes ESMOSTRUM IT particularly effective for individuals suffering from gastroesophageal reflux disease (GERD), functional dyspepsia, and other conditions where both excessive acid production and impaired gastric motility contribute to discomfort and disease progression.\nActive Pharmaceutical Ingredients\nEsomeprazole\nEsomeprazole is the S-isomer of omeprazole and belongs to the class of medications known as proton pump inhibitors (PPIs). It works by specifically and irreversibly blocking the hydrogen-potassium adenosine triphosphatase enzyme system (the proton pump) located in the gastric parietal cells. This mechanism effectively reduces gastric acid secretion, providing sustained relief from acid-related symptoms and allowing damaged esophageal and gastric tissue to heal.\nItopride\nItopride is a prokinetic agent that enhances gastrointestinal motility through a dual mechanism of action. It acts as both a dopamine D2 receptor antagonist and an acetylcholinesterase inhibitor. By blocking dopamine receptors, it removes the inhibitory effect of dopamine on gastrointestinal motility, while its acetylcholinesterase inhibition increases acetylcholine levels, further promoting coordinated gastric contractions and improved gastric emptying.\nTherapeutic Uses and Indications\nESMOSTRUM IT is prescribed for a wide range of gastrointestinal conditions where both acid suppression and enhanced motility are therapeutically beneficial:\nGastroesophageal Reflux Disease (GERD)\nESMOSTRUM IT provides exceptional relief for patients suffering from GERD, a chronic condition where stomach acid frequently flows back into the esophagus. The esomeprazole component reduces acid production, while itopride improves the tone of the lower esophageal sphincter and accelerates gastric emptying, thereby reducing the frequency and severity of reflux episodes.\nFunctional Dyspepsia\nFor patients experiencing persistent or recurrent upper abdominal discomfort without an identifiable organic cause, ESMOSTRUM IT addresses multiple pathophysiological mechanisms. It relieves symptoms such as early satiety, postprandial fullness, epigastric pain, and bloating by normalizing gastric acid levels and improving gastric accommodation and emptying.\nPeptic Ulcer Disease\nESMOSTRUM IT aids in the healing of gastric and duodenal ulcers by creating an optimal healing environment through sustained acid suppression. The prokinetic action of itopride helps prevent stasis of gastric contents, which can exacerbate ulcer symptoms.\nNon-Ulcer Dyspepsia\nMany patients experience dyspeptic symptoms without evidence of ulceration. ESMOSTRUM IT effectively manages these symptoms by addressing both acid hypersecretion and delayed gastric emptying, two key factors in non-ulcer dyspepsia.\nGastroparesis-Related Symptoms\nIn conditions where gastric emptying is significantly delayed, the itopride component of ESMOSTRUM IT helps restore more normal gastric motility patterns, reducing associated symptoms like nausea, vomiting, and abdominal distension.\nKey Benefits and Advantages\nDual Mechanism of Action\nThe primary advantage of ESMOSTRUM IT lies in its comprehensive approach to gastrointestinal health. Rather than addressing only acid production or motility in isolation, this combination therapy tackles both aspects simultaneously, providing more complete symptom relief and better therapeutic outcomes.\nSuperior Acid Suppression\nEsomeprazole offers more consistent and prolonged acid suppression compared to many other acid-reducing medications. It provides sustained relief throughout the day and night, allowing patients to experience fewer breakthrough symptoms and better quality of life.\nEnhanced Gastric Motility\nThe itopride component specifically targets motility issues without crossing the blood-brain barrier significantly, meaning it provides prokinetic benefits with minimal central nervous system side effects. This results in improved gastric emptying, reduced bloating, and decreased feelings of fullness after meals.\nRapid Symptom Relief\nMany patients experience noticeable improvement in their symptoms within the first few days of treatment with ESMOSTRUM IT. The combination therapy addresses multiple symptom pathways simultaneously, leading to faster and more comprehensive relief.\nImproved Quality of Life\nBy effectively managing symptoms such as heartburn, regurgitation, nausea, bloating, and early satiety, ESMOSTRUM IT significantly enhances patients' daily functioning and overall well-being. Patients report better sleep quality, improved dietary tolerance, and reduced anxiety related to their digestive symptoms.\nConvenient Dosing\nThe combination of two active ingredients in a single formulation improves medication adherence by reducing pill burden. Patients appreciate the simplicity of taking one medication instead of multiple separate preparations.\nMucosal Healing Properties\nBeyond symptom relief, ESMOSTRUM IT promotes actual healing of damaged esophageal and gastric mucosa. The reduced acid environment created by esomeprazole allows inflamed and eroded tissue to regenerate properly.\nReduced Risk of Complications\nBy effectively controlling acid reflux and improving gastric emptying, ESMOSTRUM IT helps prevent potential complications of chronic GERD, such as esophageal strictures, Barrett's esophagus, and respiratory complications from aspiration.\nDosage and Administration\nESMOSTRUM IT should be taken exactly as prescribed by a healthcare professional. Typically, the medication is administered orally, preferably before meals to optimize its therapeutic effects. The standard dosing regimen usually involves once or twice daily administration, though individual requirements may vary based on the severity of the condition and patient response.\nThe medication should be swallowed whole with water and should not be crushed, chewed, or split, as this may affect the drug's release mechanism and therapeutic efficacy. Patients should maintain regular dosing schedules to ensure optimal acid suppression and motility enhancement throughout the day.\nSide Effects and Safety Considerations\nLike all medications, ESMOSTRUM IT may cause side effects in some individuals, though not everyone experiences them. Understanding potential adverse effects helps patients identify and report concerning symptoms promptly.\nCommon Side Effects\nGastrointestinal Effects: Some patients may experience diarrhea, constipation, abdominal pain, nausea, or flatulence, particularly during initial treatment. These effects are usually mild and often resolve as the body adjusts to the medication.\nHeadache: Mild to moderate headaches occur in a small percentage of patients and typically diminish with continued use.\nDizziness: Some individuals may experience lightheadedness or dizziness, particularly when standing up quickly.\nDry Mouth: Reduced saliva production may occur, leading to oral dryness and discomfort.\nLess Common Side Effects\nSkin Reactions: Rash, itching, or other dermatological manifestations may develop in sensitive individuals.\nSleep Disturbances: Some patients report insomnia or unusual dreams while taking the medication.\nIncreased Prolactin Levels: Itopride may cause mild elevation in prolactin levels, though clinical manifestations are rare.\nTaste Alterations: Changes in taste perception or metallic taste may occur temporarily.\nSerious Side Effects (Rare)\nWhile uncommon, certain serious adverse effects require immediate medical attention:\n\nSevere allergic reactions including difficulty breathing, facial swelling, or severe skin reactions\nSevere diarrhea that persists or contains blood\nIrregular heartbeat or palpitations\nMuscle weakness or pain\nSeizures or tremors\nSigns of liver problems including jaundice, dark urine, or persistent nausea\n\nLong-Term Considerations\nExtended use of proton pump inhibitors like esomeprazole has been associated with certain risks that patients should discuss with their healthcare providers:\n\nPotential reduction in calcium, magnesium, and vitamin B12 absorption\nSlightly increased risk of bone fractures with prolonged use\nPossible increased susceptibility to certain gastrointestinal infections\nRare cases of kidney problems\n\nRegular monitoring and periodic assessment by healthcare professionals help minimize these risks while maintaining therapeutic benefits.\nPrecautions and Contraindications\nPatients should inform their healthcare provider about all existing medical conditions, particularly liver disease, kidney problems, osteoporosis, low magnesium levels, or any gastrointestinal bleeding. ESMOSTRUM IT may interact with certain medications, including blood thinners, antifungals, HIV medications, and certain antibiotics. A complete medication review ensures safe and effective therapy.\nPregnant or breastfeeding women should only use ESMOSTRUM IT under strict medical supervision, as the safety profile in these populations requires careful consideration of potential risks and benefits.\nLifestyle Recommendations\nFor optimal therapeutic outcomes, patients taking ESMOSTRUM IT should complement their medication regimen with appropriate lifestyle modifications:\n\nAvoid trigger foods that exacerbate acid reflux, such as spicy foods, citrus, chocolate, caffeine, and alcohol\nMaintain a healthy body weight to reduce abdominal pressure\nEat smaller, more frequent meals rather than large portions\nAvoid lying down immediately after eating; wait at least two to three hours\nElevate the head of the bed if nighttime symptoms occur\nQuit smoking, as tobacco use significantly worsens reflux symptoms\nManage stress through relaxation techniques, as stress can exacerbate digestive symptoms\n\nConclusion\nESMOSTRUM IT represents a sophisticated and effective pharmaceutical solution for individuals struggling with complex gastrointestinal disorders involving both acid hypersecretion and impaired motility. By combining the powerful acid-suppressing capabilities of esomeprazole with the prokinetic benefits of itopride, this medication offers comprehensive symptom management that addresses the multifaceted nature of digestive disorders.", "price": 182.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2273, "imageuri": "https://productimages.withfloats.com/actual/69623e6fd8491171373812e3.png", "tileimageuri": "https://productimages.withfloats.com/tile/69623e6fd8491171373812e3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-10T11:56:28.061Z", "updatedon": "2026-04-21T09:38:56.999Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//esomeprazole-and-itopride/2273", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ESMOSTRUM IT", "category": "GASTROLOGYRANGE", "tags": [ "esomeprazole and itopride", "esomeprazole and itopride capsules uses in hindi", "esomeprazole and itopride capsules uses", "esomeprazole and itopride brand name", "esomeprazole and itopride hydrochloride", "esomeprazole and itopride capsules", "esomeprazole and itopride uses", "esomeprazole and itopride hydrochloride capsules", "esomeprazole and itopride hydrochloride uses", "esomeprazole and itopride hydrochloride price", "esomeprazole and itopride hydrochloride price in india", "buy online Esomeprazole and Itopride" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694e56c05837f90c86a7eb8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin linagliptin and metformin", "description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n​\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n​\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n​\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n​\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n​\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n​\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n​\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n​\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n​\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n​\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n​\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n​\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n​\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n​\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n​\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n​\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n​\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n​\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n​\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n​\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n​\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n​\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n​\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n​\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n​\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n​\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n​\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.", "price": 220.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2257, "imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png", "tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-26T09:34:56.604Z", "updatedon": "2026-03-13T10:59:31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-linagliptin-and-metformin/2257", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGIP EMPAMET", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 10 mg", "empagliflozin 25 mg", "empagliflozin 10 mg uses in hindi", "empagliflozin 10 mg tablet.", "type 2 diabetes mellitus.", "linagliptin", "Linagliptin 5 mg", "linagliptin 5 mg uses", "linagliptin tablet uses", "Linagliptin 5 mg price", "Empagliflozin, an SGLT2 inhibitor.", "Metformin ER reduces hepatic glucose production and improves insulin.", "LINALIGIP EMPAMET revolutionizes type 2 diabetes.", "empagliflozin linagliptin and metformin tablets", "empagliflozin linagliptin metformin combination tablet", "empagliflozin linagliptin metformin tablets uses", "empagliflozin linagliptin metformin triple combination", "empagliflozin linagliptin metformin dosage strength", "empagliflozin linagliptin metformin sustained release tablet", "empagliflozin linagliptin metformin medicine for diabetes", "empagliflozin linagliptin metformin tablet uses", "empagliflozin linagliptin metformin benefits", "empagliflozin linagliptin metformin for type 2 diabetes", "empagliflozin linagliptin metformin blood sugar control", "empagliflozin linagliptin metformin weight loss benefit", "what is empagliflozin linagliptin metformin tablet", "how does empagliflozin linagliptin metformin work", "empagliflozin linagliptin metformin tablet price in india", "empagliflozin linagliptin metformin tablet dosage", "empagliflozin linagliptin metformin before or after food" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662c321dce9381dfcc59f3d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": " Thalidomide 50mg", "description": "THALIDOMILE 100\nThalidomide (100mg)\nThalidomide (100mg) is a medication primarily used to treat certain types of cancer, such as multiple myeloma and leprosy. It belongs to a class of drugs known as immunomodulatory agents. Thalidomide works by affecting the immune system and inhibiting the growth of abnormal cells.\n\nKey points about Thalidomide (100mg):\n\nMedical Uses: Thalidomide is prescribed to patients with multiple myeloma, a type of blood cancer that affects plasma cells. It is also used in the treatment of complications related to leprosy.\nMode of Action: Thalidomide exerts its therapeutic effects by modulating the immune response and interfering with the growth of cancer cells.\nDosage: The standard dosage of Thalidomide is typically 100mg, but this may vary depending on the patient's condition and response to treatment. It is usually taken orally once daily, with or without food.\nSide Effects: Common side effects of Thalidomide include drowsiness, dizziness, constipation, and skin rash. It can also cause more serious side effects such as peripheral neuropathy and blood clots.\nPrecautions: Thalidomide is known to cause severe birth defects and should not be used during pregnancy. Patients must use effective contraception during treatment and for a period after stopping Thalidomide.\nMonitoring: Regular monitoring of blood cell counts, liver function, and pregnancy tests (for women of childbearing potential) is necessary during Thalidomide therapy.\nIt's crucial to take Thalidomide exactly as prescribed by a healthcare professional and to report any unusual symptoms or side effects promptly. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\n", "price": 561.0, "discountamount": 168.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Mode", "Call", "food", "100mg", "Order", "women", "drugs", "Email", "types", "class", "period", "Action", "growth", "leprosy", "patients", "WhatsApp", "dizziness", "treatment", "condition", "skin rash", "medication", "Key points", "drowsiness", "Precautions", "information", "blood clots", "THALIDOMILE", "constipation", "sterispharma", "sterisonline", "plasma cells", "Medical Uses", "cancer cells", "blood cancer", "immune system", "complications", "abnormal cells", "liver function", "pregnancy tests", "immune response", "standard dosage", "unusual symptoms", "multiple myeloma", "blood cell counts", "Regular monitoring", "Thalidomide therapy", "therapeutic effects", "Common side effects", "serious side effects", "severe birth defects", "peripheral neuropathy", "childbearing potential", "healthcare professional", "effective contraception", "immunomodulatory agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1510, "imageuri": "https://productimages.withfloats.com/actual/667d3f16422dd0be26725b95.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3f16422dd0be26725b95.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:21:53.58Z", "updatedon": "2026-01-13T12:30:44.037Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//-thalidomide-50mg/1510", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "THALIDOMILE 100", "category": "NEPHROLOGYRANGE", "tags": [ "thalidomide 100mg price", "thalidomide capsules 100 mg", "thalidomide 100mg side effects", "", "thalidomide 100 mg brands" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662bfd9ea22b014e8af3a11", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "THALIDOMILE 100", "description": "THALIDOMILE 100\nThalidomide (100mg)\nThalidomide (100mg) is a medication primarily used for treating certain types of skin conditions like erythema nodosum leprosum (ENL) and multiple myeloma. It belongs to a class of drugs known as immunomodulatory agents. Thalidomide works by modulating the immune system and reducing inflammation, which helps in managing the symptoms associated with these conditions.\n\nThis medication comes in the form of oral capsules containing 100mg of thalidomide. It is usually taken once daily with food to improve absorption and reduce the risk of stomach upset. The dosage may vary depending on the condition being treated and the individual's response to the treatment.\n\nIt's important to follow your healthcare provider's instructions carefully when taking thalidomide. This medication may cause drowsiness, dizziness, or constipation, so it's advisable to avoid activities that require alertness until you know how it affects you. Additionally, thalidomide should not be taken during pregnancy as it can cause severe birth defects.\n\nBefore starting thalidomide, inform your doctor about any other medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions. Regular monitoring of blood counts and liver function may be necessary while on thalidomide therapy.\n\nOverall, thalidomide (100mg) is an important medication for managing certain skin conditions and multiple myeloma, but it should be used under the supervision of a healthcare professional due to its potential side effects and risks.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\nhttps://www.sterisonline.com/product/thalidomile-100-133690\n\n\n\n\n\n\n\n", "price": 599.0, "discountamount": 180.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "ENL", "Call", "form", "food", "risk", "100mg", "Email", "Order", "types", "class", "dosage", "doctor", "response", "symptoms", "WhatsApp", "pregnancy", "treatment", "dizziness", "alertness", "absorption", "individual", "drowsiness", "activities", "supplements", "supervision", "THALIDOMILE", "constipation", "sterispharma", "instructions", "sterisonline", "blood counts", "inflammation", "counter drugs", "immune system", "stomach upset", "oral capsules", "liver function", "skin conditions", "multiple myeloma", "other medications", "Regular monitoring", "thalidomide therapy", "healthcare provider", "important medication", "severe birth defects", "potential interactions", "potential side effects", "immunomodulatory agents", "healthcare professional", "erythema nodosum leprosum" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1508, "imageuri": "https://productimages.withfloats.com/actual/6662bfdcc749b7962dbd43e4.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662bfdcc749b7962dbd43e4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:07:53.656Z", "updatedon": "2026-03-13T06:00:59.557Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//thalidomile-100/1508", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "THALIDOMILE 100", "category": "NEPHROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662b286db9fdd21801f040b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LENALIMIDE 25", "description": "LENALIMIDE 25\nLenalidomide (25mg)\nLenalidomide 25mg is a medication primarily used to treat certain types of cancers, such as multiple myeloma and myelodysplastic syndromes (MDS). It belongs to a class of drugs known as immunomodulators, which work by affecting the immune system and helping the body fight cancer cells.\n\nThis medicine comes in the form of oral capsules, each containing 25mg of lenalidomide. It is usually taken once daily with water, either with or without food, as directed by your doctor.\n\nLenalidomide works by inhibiting the growth of cancer cells and reducing the formation of new blood vessels in tumors. This can help slow down or stop the progression of cancer.\n\nCommon side effects of lenalidomide may include nausea, diarrhea, constipation, dizziness, fatigue, and low blood cell counts (anemia, neutropenia, thrombocytopenia). It's important to report any severe or persistent side effects to your healthcare provider.\n\nBefore taking lenalidomide, inform your doctor about any other medications you are taking, as well as any medical conditions you have, especially if you are pregnant or planning to become pregnant, as lenalidomide can cause birth defects.\n\nOverall, lenalidomide 25mg is a valuable treatment option for certain cancers and should be used under the supervision of a qualified healthcare professional.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \nhttps://www.sterisonline.com/product/lenalimide-25-133663\n\n\n\n\n\n\n\n", "price": 3100.0, "discountamount": 930.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDS", "form", "body", "food", "water", "class", "Order", "types", "Email", "drugs", "tumors", "nausea", "growth", "anemia", "severe", "doctor", "fatigue", "cancers", "medicine", "WhatsApp", "diarrhea", "dizziness", "LENALIMIDE", "supervision", "neutropenia", "progression", "constipation", "sterispharma", "sterisonline", "cancer cells", "birth defects", "oral capsules", "immune system", "multiple myeloma", "thrombocytopenia", "immunomodulators", "new blood vessels", "Lenalidomide 25mg", "other medications", "medical conditions", "healthcare provider", "Common side effects", "low blood cell counts", "persistent side effects", "valuable treatment option", "myelodysplastic syndromes", "qualified healthcare professional" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1500, "imageuri": "https://productimages.withfloats.com/actual/667d4a8d1657b0caada580a8.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d4a8d1657b0caada580a8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T07:11:02.191Z", "updatedon": "2026-03-12T12:25:07.081Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//lenalimide-25/1500", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LENALIMIDE 25", "category": "NEPHROLOGYRANGE", "tags": [ "lenalidomide 25 mg price in india", "lenalidomide 25 mg dose", "lenalidomide side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662b14bdb9fdd21801f0392", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": " lenalidomide 10 mg", "description": "LENALIMIDE 10\nCancer treatment today is no longer limited to aggressive chemotherapy alone. Modern therapies focus on precision, immune modulation, and long-term disease control. LENALIMIDE 10, containing Lenalidomide 10 mg, represents this new generation of targeted cancer medicines. It is widely prescribed by oncologists for the treatment of several hematological malignancies, particularly multiple myeloma and certain blood disorders.\n\nLENALIMIDE 10 is an oral immunomodulatory medicine designed to help the body’s immune system recognize and fight abnormal cancer cells more effectively while slowing disease progression and improving patient outcomes.\n\nProduct Composition\n\nEach capsule of LENALIMIDE 10 contains:\n\nLenalidomide IP 10 mg\n\nLenalidomide is a potent derivative of thalidomide, developed to provide superior therapeutic efficacy with improved safety and tolerability. It belongs to a class of medicines known as immunomodulatory agents (IMiDs).\n\nProduct Uses of Lenalidomide 10 mg\n\nLENALIMIDE 10 is primarily used in the management of blood-related cancers and bone marrow disorders. It is commonly prescribed for:\n\nMultiple Myeloma\nUsed alone or in combination with other medicines such as dexamethasone to slow the growth of cancerous plasma cells.\n\nMyelodysplastic Syndromes (MDS)\nParticularly in patients with specific genetic abnormalities, where it helps reduce anemia and dependence on blood transfusions.\n\nMantle Cell Lymphoma (MCL)\nPrescribed in cases where the disease has relapsed or progressed after previous treatment.\n\nDoctors may also recommend Lenalidomide 10 mg as maintenance therapy following stem cell transplantation to prolong remission and improve long-term survival.\n\nHow LENALIMIDE 10 Works\n\nLenalidomide 10 mg works through multiple mechanisms, making it highly effective in cancer therapy:\n\nEnhances immune system response by activating T-cells and natural killer (NK) cells\n\nSuppresses inflammatory cytokines that support tumor growth\n\nPrevents the formation of new blood vessels that feed cancer cells\n\nDirectly inhibits the growth and survival of malignant cells\n\nBy targeting cancer cells while strengthening immune defense, LENALIMIDE 10 offers a balanced and targeted approach to treatment.\n\nKey Benefits of LENALIMIDE 10\n\nLENALIMIDE 10 provides several important benefits for patients and healthcare providers:\n\nImproved Disease Control\nHelps slow disease progression and reduces cancer cell multiplication.\n\nImmune System Support\nStrengthens the body’s natural ability to fight cancer.\n\nOral Convenience\nTaken as a capsule, making long-term therapy easier compared to injectable treatments.\n\nProven Clinical Effectiveness\nBacked by extensive clinical studies demonstrating improved survival and response rates.\n\nMaintenance Therapy Option\nUseful for prolonged disease management after initial treatment success.\n\nBetter Quality of Life\nAllows patients to continue treatment with fewer hospital visits.\n\nSide Effects of Lenalidomide 10 mg\n\nLike all cancer medicines, LENALIMIDE 10 may cause side effects. These vary from patient to patient and depend on dosage, treatment duration, and overall health.\n\nCommon Side Effects\n\nFatigue or weakness\n\nNausea or vomiting\n\nDiarrhea or constipation\n\nLoss of appetite\n\nHeadache\n\nSkin rash or itching\n\nMuscle cramps\n\nThese side effects are usually manageable with supportive care and medical supervision.\n\nSerious Side Effects\n\nAlthough less common, some patients may experience serious side effects, including:\n\nLow blood cell counts (anemia, neutropenia, thrombocytopenia)\n\nIncreased risk of infections\n\nBlood clot formation (deep vein thrombosis or pulmonary embolism)\n\nLiver function abnormalities\n\nSevere allergic reactions\n\nRegular blood tests and medical monitoring are essential during treatment with LENALIMIDE 10.\n\nPrecautions and Safety Information\n\nNot safe during pregnancy due to risk of severe birth defects\n\nEffective contraception is mandatory during and after treatment\n\nNot recommended during breastfeeding\n\nCaution required in patients with kidney or liver disease\n\nAvoid blood donation while taking this medicine\n\nPatients should strictly follow their doctor’s instructions and report any unusual symptoms immediately.\n\nConclusion\n\nLENALIMIDE 10 (Lenalidomide 10 mg) is a clinically proven and widely trusted immunomodulatory therapy for the treatment of multiple myeloma and other hematological disorders. By combining targeted anti-cancer action with immune system support, it plays a vital role in modern oncology treatment strategies. When used under proper medical supervision, LENALIMIDE 10 can help improve survival, control disease progression, and enhance the overall quality of life for patients.\n\n\n\n\n\n\n", "price": 889.0, "discountamount": 267.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDS", "Call", "food", "part", "rash", "Email", "Order", "drugs", "class", "types", "doctor", "dosage", "growth", "anemia", "nausea", "fatigue", "diarrhea", "decrease", "Patients", "schedule", "WhatsApp", "guidance", "dizziness", "therapies", "LENALIMIDE", "infections", "new cancers", "neutropenia", "combination", "description", "sterispharma", "sterisonline", "Lenalidomide", "cancer cells", "constipation", "immune system", "effectiveness", "medical advice", "potential risk", "thrombocytopenia", "multiple myeloma", "blood cell counts", "other medications", "Common side effects", "serious side effects", "informational purposes", "potential side effects", "healthcare professional", "immunomodulatory agents", "myelodysplastic syndromes", "comprehensive treatment plan", "qualified healthcare provider" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1498, "imageuri": "https://productimages.withfloats.com/actual/6662b14e0d2c64b6857b65b2.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662b14e0d2c64b6857b65b2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T07:05:47.874Z", "updatedon": "2026-04-15T12:17:07.104Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//-lenalidomide-10-mg/1498", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LENALIMIDE 10", "category": "NEPHROLOGYRANGE", "tags": [ "lenalidomide 10 mg", "tab lenalidomide 10 mg", "lenalidomide 10 mg price", "lenalidomide 10 mg uses", "lenalidomide 10 mg uses in hindi", "lenalidomide 10 mg price in india", "lenalidomide 10 mg tablet side effects", "tab lenalidomide 10 mg uses", "lenalidomide 10 mg price in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66604960a743fd235821fba0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "IMEGLIMON 500 ", "description": "IMEGLIMON 500 \nImeglimin Hydrochloride 500 mg\nIntroduction to IMEGLIMON 500\nIMEGLIMON 500 contains Imeglimin Hydrochloride 500mg, a novel oral medication used for the management of type 2 diabetes mellitus. Imeglimin represents a new class of oral antidiabetic agents known as \"glimins,\" which target multiple pathways involved in glucose metabolism. This medication helps improve blood sugar control by enhancing insulin sensitivity, increasing insulin secretion, and improving mitochondrial function.\n\nWhat is Imeglimin?\nOverview of Imeglimin\nImeglimin is an innovative oral antidiabetic agent that works through a multifaceted mechanism to improve glycemic control in patients with type 2 diabetes. Unlike traditional antidiabetic medications, Imeglimin targets multiple defects associated with type 2 diabetes, providing a comprehensive approach to managing blood sugar levels.\n\nMechanism of Action\nInsulin Sensitization: Imeglimin enhances insulin sensitivity in muscle and liver tissues, leading to improved glucose uptake and utilization.\nInsulin Secretion: It increases insulin secretion in response to glucose, helping to maintain more stable blood sugar levels.\nMitochondrial Function: Imeglimin improves mitochondrial function, which helps to reduce oxidative stress and improve overall cellular energy metabolism.\nBenefits of IMEGLIMON 500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: IMEGLIMON 500 helps regulate both postprandial (after-meal) and fasting blood glucose levels by improving insulin sensitivity and secretion.\nComprehensive Glycemic Control: The unique mechanism of action of Imeglimin addresses multiple pathways involved in glucose metabolism, providing comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: IMEGLIMON 500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, IMEGLIMON 500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nImproved Mitochondrial Function: The positive effects on mitochondrial function can lead to reduced oxidative stress and improved overall cellular health.\nWeight Management: Imeglimin has a neutral effect on body weight, making it a suitable option for patients concerned about weight gain associated with some antidiabetic medications.\nHow to Use IMEGLIMON 500\nDosage and Administration\nRecommended Dosage: The typical dosage of IMEGLIMON 500 is one tablet taken twice daily, with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to enhance absorption and reduce the risk of gastrointestinal discomfort. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take IMEGLIMON 500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/imeglimon-500-134379", "price": 159.0, "discountamount": 47.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "Diet", "EMAIL", "Order", "water", "meals", "Action", "muscle", "option", "glimins", "Support", "patients", "readings", "Overview", "new class", "IMEGLIMON", "one tablet", "absorption", "Guidelines", "full glass", "neuropathy", "Optimal Use", "utilization", "body weight", "weight gain", "retinopathy", "Adjustments", "information", "Postprandial", "Reduced Risk", "sterispharma", "Introduction", "best results", "sterisonline", "CALL/WHATSAPP", "liver tissues", "Administration", "glucose uptake", "Consistent Use", "neutral effect", "treatment plan", "typical dosage", "positive effects", "multiple defects", "unique mechanism", "Exercise Adjunct", "oxidative stress", "Weight Management", "multiple pathways", "excellent adjunct", "insulin secretion", "glucose metabolism", "Recommended Dosage", "Diabetes Management", "blood sugar control", "insulin sensitivity", "individual response", "healthcare provider", "blood glucose levels", "Insulin Sensitization", "novel oral medication", "multifaceted mechanism", "cardiovascular disease", "comprehensive approach", "mitochondrial function", "overall cellular health", "Fasting Glucose Control", "lifestyle modifications", "Imeglimin Hydrochloride", "long-term complications", "type 2 diabetes mellitus", "oral antidiabetic agents", "stable blood sugar levels", "Additional Health Benefits", "gastrointestinal discomfort", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "overall cellular energy metabolism", "innovative oral antidiabetic agent", "traditional antidiabetic medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1375, "imageuri": "https://productimages.withfloats.com/actual/66604962487c46164ce29d69.png", "tileimageuri": "https://productimages.withfloats.com/tile/66604962487c46164ce29d69.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:17:52.343Z", "updatedon": "2026-03-13T09:57:54.983Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//imeglimon-500-/1375", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMEGLIMON 500 ", "category": "DIABETIC RANGE", "tags": [ "IMEGLIMON 500", "Imeglimin Hydrochloride 500 mg", "Imeglimin hydrochloride 500 mg uses", "Imeglimin 500 Uses in Hindi", "Imeglimin 500 price", "Imeglimin hydrochloride tablets 1000mg", "Imeglimin side effects", "Imeglimin dose" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }